Literature DB >> 25286749

Delayed flare reaction of draining vein due to subcutaneous bortezomib more likely to occur at the inner thigh.

Osamu Imataki1, Sayoko Ota, Mariko Aoyama, Hiroyuki Kubo, Yukiko Hamasaki, Jun-ichiro Kida, Maki Oku, Makiko Uemura, Yukiko Ohue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25286749     DOI： 10.1007/s12185-014-1683-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

1.  Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.

Authors:  Philippe Moreau; Halyna Pylypenko; Sebastian Grosicki; Ievgenii Karamanesht; Xavier Leleu; Maria Grishunina; Grigoriy Rekhtman; Zvenyslava Masliak; Tadeusz Robak; Anna Shubina; Bertrand Arnulf; Martin Kropff; James Cavet; Dixie-Lee Esseltine; Huaibao Feng; Suzette Girgis; Helgi van de Velde; William Deraedt; Jean-Luc Harousseau
Journal:  Lancet Oncol       Date:  2011-04-18       Impact factor: 41.316

2.  Higher incidence of injection site reactions after subcutaneous bortezomib administration on the thigh compared with the abdomen.

Authors:  Tomohiko Kamimura; Toshihiro Miyamoto; Noriko Yokota; Shuichiro Takashima; Yong Chong; Yoshikiyo Ito; Koichi Akashi
Journal:  Eur J Haematol       Date:  2013-01-09       Impact factor: 2.997

3.  High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomib.

Authors:  Tomohiko Kamimura; Toshihiro Miyamoto; Noriko Yokota; Takatoshi Aoki; Yoshikiyo Ito; Koichi Akashi
Journal:  Int J Hematol       Date:  2013-11-19       Impact factor: 2.490
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.